Hot Investor Mandate: USA Investment Fund with Family Office Partnership Makes Seed Investments in Pre-Clinical Therapeutics Companies

7 Mar

A life sciences investment fund dedicated to accelerating the growth of seed-stage therapeutics companies with a partnership with a USA-based family investment office, seeks to make 3-5 new investments per year allocating up to $250,000 per company. The firm invests in companies based in the U.S.

The firm is seeking investments in biotech/therapeutics companies and is not interested in medical device or digital health technologies. The firm is interested in companies with assets or platform technologies in preclinical or early clinical development and is indication agnostic.

The firm does not have any company management team requirements.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: